Monte Rosa Therapeutics, Inc.
Total Trades
22
Buys
1
Sells
15
Largest Trade
N/A
Insiders
8
Institutional Funds
117
Inst. Value
$1M+
Activist Filings
39
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dunn Edmund | Principal Accounti… | SELL | $1K–$15K | 139 | $17.96 | Mar 5, 2026 |
| Warmuth Markus | President & CEO | SELL | $50K–$100K | 5K | $17.92 | Mar 4, 2026 |
| Dunn Edmund | Principal Accounti… | SELL | $100K–$500K | 26K | $18.09 | Mar 2, 2026 |
| Dunn Edmund | Principal Accounti… | EXERCISE | $100K–$500K | 26K | $13.41 | Mar 2, 2026 |
| Janku Filip | Chief Medical Offi… | SELL | $100K–$500K | 9K | $19.50 | Feb 24, 2026 |
| Warmuth Markus | President & CEO | SELL | $100K–$500K | 5K | $23.49 | Jan 9, 2026 |
| Nickson Philip | Chief Business & L… | GRANT | N/A | 28K | — | Jan 5, 2026 |
| Nickson Philip | Chief Business & L… | SELL | $15K–$50K | 3K | $15.17 | Jan 5, 2026 |
| Champoux Jennifer | COO | GRANT | N/A | 35K | — | Jan 5, 2026 |
| Champoux Jennifer | COO | SELL | $15K–$50K | 3K | $15.17 | Jan 5, 2026 |
| Dunn Edmund | Principal Accounti… | SELL | $15K–$50K | 1K | $15.17 | Jan 5, 2026 |
| Warmuth Markus | President & CEO | GRANT | N/A | 90K | — | Jan 5, 2026 |
| Warmuth Markus | President & CEO | SELL | $100K–$500K | 10K | $15.17 | Jan 5, 2026 |
| Janku Filip | Chief Medical Offi… | SELL | $15K–$50K | 3K | $15.17 | Jan 5, 2026 |
| Janku Filip | Chief Medical Offi… | GRANT | N/A | 31K | — | Jan 5, 2026 |
| Townson Sharon | Chief Scientific O… | SELL | $15K–$50K | 3K | $15.17 | Jan 5, 2026 |
| Townson Sharon | Chief Scientific O… | GRANT | N/A | 35K | — | Jan 5, 2026 |
| Dunn Edmund | Principal Accounti… | SELL | $1K–$15K | 2K | $4.45 | Jun 4, 2025 |
| Leo Chandra P. | Director | BUY | $50K–$100K | 10K | $5.84 | Mar 25, 2025 |
| Versant Venture Capital VI, L.P. | 10% Owner | SELL | $1M+ | 158K | $9.44 | Oct 30, 2024 |
| Versant Venture Capital VI, L.P. | 10% Owner | SELL | $1M+ | 1.1M | $6.53 | Sep 24, 2024 |
| Dunn Edmund | Principal Accounti… | SELL | $1K–$15K | 1K | $4.04 | Jun 5, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 117 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEA Management Company, LLC | 7.7M | $1M+ | SH |
| Versant Venture Management, LLC | 4.4M | $1M+ | SH |
| STATE STREET CORP | 2.1M | $1M+ | SH |
| Aisling Capital Management LP | 1.5M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.3M | $1M+ | SH |
| MPM BioImpact LLC | 1.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.0M | $1M+ | SH |
| BRAIDWELL LP | 948K | $1M+ | SH |
| Alphabet Inc. | 745K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 515K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 449K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 308K | $1M+ | SH |
| Nextech Invest, Ltd. | 279K | $1M+ | SH |
| Empowered Funds, LLC | 278K | $1M+ | SH |
| Empowered Funds, LLC | 278K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 248K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 216K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 216K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 213K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
3.1%
2.1M shares
SC 13G/A · Jan 21, 2026
8.7%
5.7M shares
Versant Venture Capital VI, L.P.
SC 13D/A · Jan 9, 2026
3.4%
2.2M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Nov 14, 2025
7.5%
4.6M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
Versant Venture Capital VI, L.P.
SC 13D/A · Nov 12, 2025
5.1%
3.3M shares
SC 13G/A · Oct 31, 2025
4.8%
3.0M shares
SC 13G · Oct 17, 2025
3.6%
2.2M shares
SC 13G · Oct 3, 2025
7.7%
4.8M shares
SC 13G/A · Aug 14, 2025
6.1%
3.7M shares
SC 13G/A · Jun 6, 2025
2.8%
1.8M shares
SC 13G/A · May 15, 2025
4.7%
2.9M shares
SUVRETTA CAPITAL MANAGEMENT, LLC
SC 13G · Apr 16, 2025
5.5%
3.4M shares
SC 13G/A · Feb 14, 2025
7.1%
4.3M shares
SC 13G · Feb 4, 2025
6.3%
3.8M shares
SC 13G · Jan 31, 2025
3.7%
2.3M shares
SC 13G · Jan 31, 2025
5.1%
3.2M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Nov 14, 2024
10.8%
6.6M shares
SC 13G/A · Nov 12, 2024
8.3%
5.1M shares
Versant Venture Capital VI, L.P. 2.
SC 13D/A · Oct 30, 2024
6.6%
4.1M shares
Versant Venture Capital VI, L.P. 2.
SC 13D/A · Sep 24, 2024
8.3%
5.1M shares
New Enterprise Associates 17, L.P.
SC 13D/A · Aug 12, 2024
12.5%
7.7M shares
Versant Venture Capital VI, L.P. 2.
SC 13D/A · Aug 12, 2024
11.1%
6.8M shares
New Enterprise Associates 17, L.P.
SC 13D/A · May 14, 2024
15.2%
7.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Apr 10, 2024
10.2%
5.1M shares
SC 13G · Feb 14, 2024
9.8%
4.9M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
4.7%
2.4M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2024
9.9%
4.9M shares
SC 13G/A · Feb 14, 2024
9.1%
4.5M shares
Versant Venture Capital VI, L.P.
SC 13D/A · Nov 9, 2023
13.7%
6.8M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2023
1.3%
631K shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
7.6%
3.7M shares
SC 13G/A · Feb 14, 2023
8.9%
4.3M shares
SC 13G · Feb 3, 2023
7.4%
3.6M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G/A · Feb 14, 2022
1.6%
731K shares
SC 13G · Feb 11, 2022
7.1%
3.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 10, 2022
10.4%
4.9M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 10, 2022
8.9%
4.1M shares